Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2000;96:559-564
© 2000 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALBAIGES, G.
Right arrow Articles by NICOLAIDES, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ALBAIGES, G.
Right arrow Articles by NICOLAIDES, K. H.

ORIGINAL RESEARCH

One-Stage Screening for Pregnancy Complications by Color Doppler Assessment of the Uterine Arteries at 23 Weeks’ Gestation

GERARD ALBAIGES, MD, HANNAH MISSFELDER-LOBOS, MD, CHRISTOPH LEES, MD, MAURO PARRA, MD and KYPROS H. NICOLAIDES, MD

From Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital, London, United Kingdom.

Address reprint requests to: Christoph Lees, MD Harris Birthright Research Centre for Fetal Medicine King’s College Hospital, Denmark Hill London SE5 9RS United Kingdom E-mail: cclees{at}compuserve.com


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Objective: To estimate the value of screening for preeclampsia and fetal growth restriction by performing color Doppler assessment of uterine arteries at 23 weeks’ gestation in predicting adverse pregnancy outcome.

Methods: Women with singleton pregnancies who attended routine ultrasonography at 23 weeks had color Doppler uterine artery imaging. Bilateral uterine artery notches were noted and left and right uterine artery pulsatility indices (PI) were measured. A mean PI of more than 1.45 was considered increased. Screening characteristics for predicting preeclampsia and delivery of small-for-gestational-age infants were calculated.

Results: Of 1757 pregnancies, increased PI was present in 89 (5.1%) and bilateral notches were noted in 77 (4.4%). Twenty-three of 65 women (35.3%; 95% confidence interval [CI] 23.9, 48.2) had increased PI and later developed preeclampsia, and 8 of 10 (80%; 95% CI 44.4, 97.5) with preeclampsia required delivery before 34 weeks. The respective values for women with bilateral notches were 21 of 65 (32.3%; 95% CI 21.2, 45.1) and 8 of 10 (80%; 95% CI 44.4, 97.5). The sensitivity of increased PI was 30 of 143 (21%; 95% CI 14.6, 28.6) for delivery of an infant with birth weight below the tenth percentile and 7 of 10 (70% 95% CI 34.8,93.3) for birth weight below the tenth percentile delivered before 34 weeks. The respective values for bilateral notches were 19 of 143 (13.3%; 95% CI 8.2, 20) and 5 of 10 (50%; 95% CI 18.7, 81.3).

Conclusion: A one-stage color Doppler screening program at 23 weeks identified most women who subsequently developed serious complications of impaired placentation associated with delivery before 34 weeks. The screening results were similar when the high-risk group was defined as women with increased PI or bilateral notches.

Preeclampsia, fetal growth restriction (FGR), placental abruption, and some cases of fetal death during the latter half of pregnancy are believed to result from impaired placentation in early gestation.1 Deficient placentation is characterized by inadequate trophoblast invasion into the maternal spiral arteries and failure to develop low-resistance uteroplacental circulation. In the past 20 years, Doppler ultrasonographic studies of uteroplacental circulation have shown that high impedance to flow is associated with subsequent preeclampsia, FGR, and related complications.2

In our hospital, uterine artery Doppler assessment used to be an integral part of 20-week scanning that was offered to all pregnant women. Women with abnormal Doppler results were examined again at 24 weeks, and those with persistently abnormal results were followed in a high-risk clinic. The data from that two-stage approach were reported3,4 and variations on the design were described.5,6 Harrington et al4 found bilateral early diastolic notches in about 3.9% of the population, a group that contained about 54.5% of women who subsequently developed preeclampsia and 21.8% of those who delivered infants with birth weights below the tenth percentile for gestation.

Our policy on the second-trimester scan changed recently. The scan is done at 23 weeks and color Doppler is used in all cases to examine uterine arteries. This study examined the performance of one-stage color Doppler ultrasonography in predicting adverse pregnancy outcomes.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Women who had routine antenatal care at King’s College Hospital, London, an inner-city teaching hospital, had color Doppler examination of the uterine arteries at 23 weeks’ gestation (Acuson Aspen, Acuson Co., Mountain View, CA or Aloka SSD-1700, Aloka Co., Tokyo, Japan). The right and left uterine arteries were identified at the apparent crossover with the external iliac arteries, and pulsed-wave Doppler was used to obtain waveforms. When three similar consecutive waveforms were obtained, an early diastolic notch was noted, the pulsatility index (PI) was measured, and the mean PI of the two vessels was calculated.

Women with normal uterine artery Doppler received routine antenatal care. Those with bilateral uterine artery notches or those with mean PIs of 1.45 or higher constituted the screen-positive group and were followed in a high-risk clinic starting at 24 weeks’ gestation. A PI of 1.45 was chosen because it corresponds to the 95th percentile of the reference range for our population at that gestation.

Adverse outcomes were defined as preeclampsia, and birth weight less than the tenth and third percentiles for gestation7 before 34 weeks. Other adverse outcomes were fetal death and placental abruption (defined as vaginal bleeding leading to emergency delivery and evidence of retroplacental clot at delivery). Preeclampsia was defined by blood pressure of 140/90 mmHg or greater on two occasions more than 2 hours apart, with proteinuria (minimum of 300 mg per 24 hours or dipstick testing of 300 mg/L).

During the study (May through November 1998), 1941 consecutive women with singleton pregnancies who attended the ultrasonography unit had uterine artery Doppler examinations at 22 to 25 (mean, 23) weeks’ gestation. Doppler findings were recorded in a computer patient database, and thermal waveform images were retained. Complete demographic and outcome data were available for 1757 (90.6%) women. No women were subsequently excluded from the analysis. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated by using the Statistical Package for Social Sciences, version 6 (SPSS, Inc., Chicago, IL). Receiver-operating characteristic (ROC) curves for mean PI relating to adverse outcomes were generated by using a logarithmic trendline in the Microsoft Excel 97 software package (Microsoft, Inc., Redmond, WA).


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Complete demographic and outcome data were available for 1757 women (Tables 1Go and 2Go). Their mean age was 30 years (range, 18 to 44 years). Abnormal Doppler results were present in 128 women (7.3%), including 77 (4.4%) with bilateral notches, 89 (5.1%) with mean PIs above 1.45, and 38 (2.2%) with high PIs and notches. In the group with missing outcomes, the proportion with high PIs or bilateral notches was 9 of 184 (5.1%), which was similar to that in patients with complete follow-up.


View this table:
[in this window]
[in a new window]
 
Table 1. Demographic Characteristics of the Screened Population
 

View this table:
[in this window]
[in a new window]
 
Table 2. Adverse Outcomes in the Screened Population (n = 1757)
 
Sensitivity, specificity, positive and negative predictive values, and relative risks of adverse outcomes according to abnormal Doppler results are shown in Tables 3Go (bilateral uterine artery notches or mean PI above 1.45), 4Go(bilateral notches), 5Go (high mean PI), and 6Go (high mean PI and bilateral notches). Receiver-operating characteristic curves are shown for mean PIs relating to preeclampsia, preeclampsia requiring delivery before 34 weeks, delivery of infants with birth weights less than the tenth percentile, and less than the third percentile overall and before 34 weeks (Figures 1Go and 2Go).


View this table:
[in this window]
[in a new window]
 
Table 3. Screening Characteristics for Bilateral Notches or Mean Pulsatility Index Above 1.45
 

View this table:
[in this window]
[in a new window]
 
Table 4. Screening Characteristics for Bilateral Notches, Irrespective of Mean Pulsatility Index Above 1.45
 

View this table:
[in this window]
[in a new window]
 
Table 5. Screening Characteristics for Mean Pulsatility Index Above 1.45, Irrespective of Bilateral Notches
 

View this table:
[in this window]
[in a new window]
 
Table 6. Screening Characteristics for Mean Pulsatility Index Above 1.45 and Bilateral Notches
 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Receiver-operating curves of mean pulsatility index for preeclampsia. Curves of best fit are shown for the total group (dashed line) and for women who delivered before 34 weeks’ gestation (solid line).

 


View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Receiver-operating curves of mean pulsatility index for delivery of a small-for-gestational-age infant. Curves of best fit are shown for birth weight less than the tenth percentile (light dashed line) and less than the third percentile (light solid line) for the total group and weight less than the tenth percentile (dark dashed line) and less than the third percentile among women with delivery before 34 weeks’ gestation (dark solid line).

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The one-stage color Doppler uterine artery screening program at 23 weeks’ gestation classified about 5% of the population as high-risk. That group contained about 90% of women who developed preeclampsia that required delivery before 34 weeks, 70% of those whose infants had birth weights less than the tenth percentile and were delivered before 34 weeks, half of those with placental abruption that required emergency delivery, and 80% of fetal deaths. In contrast with the high sensitivity for the preceding serious adverse outcomes, the overall sensitivity for preeclampsia was about 40% and about 20% for delivery of infants with birth weights less than the tenth percentile.

Sensitivity for preeclampsia and delivery of small infants at the severe end of the spectrum were similar to those achieved in other two-stage programs. Thus, in a study of 1326 women at 19 to 21 weeks’ and 24 weeks’ gestation, Harrington et al4 reported that abnormal results on uterine artery Doppler were present in 3.9% of pregnant women, including 81.2% of those who developed preeclampsia before 34 weeks and 57.6% of those who delivered infants with birth weights below the tenth percentile before 34 weeks.

The main features of our study that distinguish it from previous ones are the use of color Doppler as the primary technique and relatively late gestation at screening. Most previous studies used continuous-wave Doppler to obtain waveforms from the uterine arteries without viewing them.8,9 With color Doppler imaging, the precise location of uterine arteries as they cross the external iliac arteries is first identified and waveforms are obtained under direct vision with pulsed-wave Doppler. Gestation of 23 weeks was selected because previous studies that examined uterine arteries at earlier gestations reported high false-positive rates (the reason that two-stage programs were developed). In those previous studies, patients were examined with routine second-trimester fetal anomaly scans (18 to 20 weeks’ gestation), and those with abnormal uterine artery waveforms underwent second-stage screening, typically at around 24 weeks. For example, in the study of Harrington et al,4 the screen-positive rate (defined as bilateral notches or a unilateral notch and resistance index of more than 0.55) at 20 weeks was 17%; this rate decreased to 8.9% at 24 weeks.

One of the major criticisms of uterine artery Doppler screening studies has been the excessive reliance on subjective assessment of uterine artery waveforms for presence or absence of early diastolic notches. Our study used only color Doppler equipment, which might be associated with more reproducible measurements of impedance indices than is continuous-wave Doppler. For the same screen-positive rate, sensitivity of PI for preeclampsia and delivery of infants with birth weights less than the tenth percentile might be better than that of bilateral notches. Although some adverse outcomes occurred in the group with bilateral notches and normal PIs, inclusion of bilateral notches in the definition of screen-positive group introduces an element of subjectivity in the program and nearly doubles the screen-positive rate but only marginally improves sensitivity.

Women at highest risk are those with bilateral notches and a high mean PI. They have a 40% chance of developing preeclampsia and 45% for delivering infants of birth weight less than the tenth percentile. Although they comprise only 2% of the screened population, the relative risks for adverse outcomes before 34 weeks and fetal death in that group range from 50 to 100, a clinical risk that merits close antenatal surveillance.

Another important finding of our study was the negative predictive value, which was more than 99% for adverse outcomes before 34 weeks, placental abruption, and fetal death. This finding suggests that uterine artery screening might be used to determine the appropriate level of antenatal care in specific women. Women with normal uterine artery Doppler results are unlikely to develop preeclampsia, FGR or placental abruption and therefore do not necessarily need antenatal follow-up that is as close as that required in women with abnormal uterine artery Doppler findings. The real value of this method of screening is that using a mean uterine artery PI above 1.45 predicts most women who will experience severe preterm consequences of impaired placentation.


    Footnotes
 
The study was supported by The Fetal Medicine Foundation (Charity number 1037116).

The authors thank Paul Seed, Division of Primary Care and Health Sciences, Guy’s, King’s and St. Thomas’s Hospitals, for valuable statistical input.

PII S0029-7844(00)00946-7

Received September 27, 1999. Received in revised form April 17, 2000. Accepted May 11, 2000.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
1. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–59.[Medline]

2. Campbell S, Pearce JMF, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: Early screening test for high-risk pregnancies. Obstet Gynecol 1986;68: 649–53.[Medline]

3. Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82: 78–83.[Abstract/Free Full Text]

4. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of preeclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182–8.[Medline]

5. North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol 1994;83:378–86.[Abstract/Free Full Text]

6. Valensise H, Bezzeccheri V, Rizzo G, Tranquilli AL, Garzetti G, Romanini C. Doppler velocimetry of the uterine artery as a screening test for gestational hypertension. Ultrasound Obstet Gynecol 1993;3:18–22.[Medline]

7. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987;15:45–52.[Medline]

8. Bewley S, Cooper D, Campbell S. Doppler investigation of uteroplacental blood flow in the second trimester: a screening study for preeclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1991;98:871–9.[Medline]

9. Harrington KF, Campbell S, Bewley S, Bower S. Doppler velocimetry studies of the uterine artery in the early prediction of preeclampsia and intra-uterine growth retardation. European Journal of Obstetrics, Gynecology and Reproductive Biology 1991;42:S14–20.




This article has been cited by other articles:


Home page
HypertensionHome page
B. Vasapollo, G. P. Novelli, and H. Valensise
Total Vascular Resistance and Left Ventricular Morphology as Screening Tools for Complications in Pregnancy
Hypertension, April 1, 2008; 51(4): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. C.S. Smith, E. Celik, M. To, O. Khouri, K. H. Nicolaides, and the Fetal Medicine Foundation Second Trimester Scr
Cervical Length at Mid-Pregnancy and the Risk of Primary Cesarean Delivery
N. Engl. J. Med., March 27, 2008; 358(13): 1346 - 1353.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. McLeod MD
How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction?
Can. Med. Assoc. J., March 11, 2008; 178(6): 727 - 729.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
G. C. S. Smith, C. K. H. Yu, A. T. Papageorghiou, A. M. Cacho, K. H. Nicolaides, and for the Fetal Medicine Foundation Second Trimester
Maternal Uterine Artery Doppler Flow Velocimetry and the Risk of Stillbirth
Obstet. Gynecol., January 1, 2007; 109(1): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Alberry and P Soothill
Management of fetal growth restriction
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F62 - F67.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
A. Conde-Agudelo, J. Villar, and M. Lindheimer
World Health Organization Systematic Review of Screening Tests for Preeclampsia
Obstet. Gynecol., December 1, 2004; 104(6): 1367 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
T. Frusca, M. Soregaroli, C. Platto, L. Enterri, A. Lojacono, and A. Valcamonico
Uterine Artery Velocimetry in Patients With Gestational Hypertension
Obstet. Gynecol., July 1, 2003; 102(1): 136 - 140.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. M. Reis, D. D'Antona, and F. Petraglia
Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy
Endocr. Rev., April 1, 2002; 23(2): 230 - 257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Lyall, H. Simpson, J. Nicola Bulmer, A. Barber, and S. Courtenay Robson
Transforming Growth Factor-{beta} Expression in Human Placenta and Placental Bed in Third Trimester Normal Pregnancy, Preeclampsia, and Fetal Growth Restriction
Am. J. Pathol., November 1, 2001; 159(5): 1827 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
C. Lees, M. Parra, H. Missfelder-Lobos, A. Morgans, O. Fletcher, and K. H. Nicolaides
Individualized Risk Assessment for Adverse Pregnancy Outcome by Uterine Artery Doppler at 23 Weeks
Obstet. Gynecol., September 1, 2001; 98(3): 369 - 373.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALBAIGES, G.
Right arrow Articles by NICOLAIDES, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ALBAIGES, G.
Right arrow Articles by NICOLAIDES, K. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS